Nabil Gharios Overview

  • Primary Position
  • Partner & Execut...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 1

  • Med. Deal Size

  • Med. Valuation

Nabil Gharios General Information

Biography

Mr. Nabil Gharios serves as a Partner & Executive Board Member at Auriga Partners (Paris). He is a Co-Founder and serves as Director at Blue Bees Therapeutics. He is the Founder of DNA Finance. Mr. Gharios serves as Portfolio Manager at Perinvest (UK). Mr. Gharios serves as President of Dna Corporate Finance. He started his career in 1999 at SG Cowen, as a financial analyst for the healthcare M&A division (NY). Between 2001-2005, He was an associate at Bioam, a €51m VCF specializing in Biotech. In 2011, He founded Biotech Promise, a specialized investment fund for listed biotech and Medtech companies. Mr. Gharios graduated from Ecole Centrale de Paris, a leading French engineering university, and is currently responsible for the healthcare sector of the French Society of Financial Analysts.

Contact Information

Primary Position
Partner & Executive Board Member, Auriga Partners (Paris)
Education
Ecole Centrale de Paris, MS (Master of Science)
Gender
Male
Email
gh
Address
  • 250 bis rue du Faubourg Saint Honoré
  • 75008 Paris
  • France

Nabil Gharios Positions (5)

Firm name Firm type Title Location Industry Since
Auriga Partners (Paris) Investor Partner & Executive Board Member Paris, France Venture Capital
Blue Bees Therapeutics Company Co-Founder & Director Orsay, France Drug Delivery
Dna Corporate Finance Service Provider President Paris, France Financing Advisory
DNA Finance Service Provider Founder Paris, France Financing Advisory
Perinvest (UK) Investor Portfolio Manager London, United Kingdom Hedge Fund

Nabil Gharios Board Seats (1)

Company Industry Ownership Status Financing Status Location Since
Auriga Partners (Paris) Paris, France

Nabil Gharios Lead Partner on Deals (1)

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Healshape 31-Dec-2022 Early Stage VC (Series A) Completed Biotechnology Nantes, France

Nabil Gharios Network (12)

Board Members (6)

Name Company Representing Location From
Patrick Bamas Auriga Partners (Paris) Auriga Partners (Paris) Paris, France
Jacques Chatain Auriga Partners (Paris) Self Paris, France
Auriga Partners (Paris) Self Paris, France
Auriga Partners (Paris) Auriga Partners (Paris) Paris, France
Auriga Partners (Paris) Self Paris, France

Portfolio Executives (6)

Name Company Role Deal date Location
Amelie Thepot Healshape Co-Founder, Chief Operating Officer & Scientific Partnerships Executive 31-Dec-2022 Nantes, France
Christophe Marquette Healshape Co-Founder 31-Dec-2022 Nantes, France
Healshape Co-Founder & Chief Development Officer 31-Dec-2022 Nantes, France
Healshape Co-Founder, Chief Executive Officer 31-Dec-2022 Nantes, France
Healshape Co-Founder & Special Advisor to the CEO 31-Dec-2022 Nantes, France

Nabil Gharios FAQs

  • Who is Nabil Gharios?

    Mr. Nabil Gharios serves as a Partner & Executive Board Member at Auriga Partners (Paris).

  • How much does Nabil Gharios typically invest?

    Nabil Gharios's median deal size is .

  • What is Nabil Gharios’s main position?

    Nabil Gharios’s primary position is Partner & Executive Board Member.

  • How many active board seats does Nabil Gharios hold?

    Nabil Gharios holds a board seat in Auriga Partners (Paris).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »